← CRS Congressional Research Service reports

Pharmaceutical Patent Disputes: Biosimilar Entry Under the Biologics Price Competition and Innovation Act (BPCIA)

IF · In Focus (2-page brief) · 2025-06-12 · IF13029

Report

CRS ID
IF13029
Series
In Focus (2-page brief)
Publication date
2025-06-12

Documents

PDF
https://www.everycrsreport.com/files/2025-06-12_IF13029_6951b4341074a0c84eaa5745e77dc082f15b343e.pdf
HTML
https://www.everycrsreport.com/files/2025-06-12_IF13029_af9f98f4ac0f4fd539038ed9e7abf0280218035f.html
Source
EveryCRSReport.com
Machine
JSON-LD · Markdown